26-Jun-2026
Business Wire (Thu, 25-Jun 9:00 AM ET)
Plus Therapeutics wins Elevance Health coverage deal
Seeking Alpha News (Thu, 25-Jun 8:02 AM ET)
Business Wire (Wed, 24-Jun 3:00 PM ET)
10 large and mega-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha News (Wed, 24-Jun 9:35 AM ET)
15 dividend stocks outpacing Wall Street as the Nasdaq and S&P 500 struggle
Seeking Alpha News (Tue, 23-Jun 1:10 PM ET)
Elevance Health Makes Clinical Review Faster, More Connected with Health OS
Business Wire (Tue, 23-Jun 8:15 AM ET)
Business Wire (Wed, 17-Jun 10:00 AM ET)
Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support
Business Wire (Mon, 15-Jun 10:00 AM ET)
Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide
Business Wire (Wed, 27-May 6:46 AM ET)
Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care
Business Wire (Mon, 4-May 2:10 PM ET)
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance Health trades on the NYSE stock market under the symbol ELV.
As of June 26, 2026, ELV stock price climbed to $395.18 with 2,335,136 million shares trading.
ELV has a beta of 0.58, meaning it tends to be less sensitive to market movements. ELV has a correlation of 0.04 to the broad based SPY ETF.
ELV has a market cap of $85.82 billion. This is considered a Large Cap stock.
Last quarter Elevance Health reported $49 billion in Revenue and $12.58 earnings per share. This beat revenue expectation by $2 billion and exceeded earnings estimates by $1.84.
In the last 3 years, ELV traded as high as $567.26 and as low as $273.71.
The top ETF exchange traded funds that ELV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
ELV has underperformed the market in the last year with a price return of +7.7% while the SPY ETF gained +20.4%. However, in the short term, ELV had mixed performance relative to the market. It has outperformed in the last 3 months, returning +34.9% vs +13.3% return in SPY. But in the last 2 weeks, ELV shares have been beat by the market, returning -2.2% compared to an SPY return of -1.5%.
ELV support price is $379.49 and resistance is $395.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELV shares will trade within this expected range on the day.